ARCHIVES

PD-1 Checkpoint Inhibitor Opdivo First to Demonstrate Survival Benefit in Phase III

This article is from The Cancer Letter archive.

Vol. 37 No. 11 | November 28, 2014

Download PDF Visit The Full Archive

Related Articles

Upton Still Mum On Leaving; DeVita Ever More Likely as Replacement

November 30, 1979

Steckel Object To Remarks By Korn Comparing Southern California Centers Unfavorably To NCCP Consortium

November 2, 1984

In Brief: $7 Mil. Gift allows USC To Expand Gene Therapy; North Carolina Passes Off-Label Drug Legislation

September 3, 1993

In Brief: John Kovach Succeeds Moertel As Mayo CC Head; DEA Deputy Appointed; New NCAB Member Named

February 7, 1986

Hairy Cell Leukemia Patients Have CRs In Phase I Trial

September 28, 2001

Funding For Groups, Working With Industry, Still Unresolved

June 12, 1998